Coronavirus COVID-19 Updates: uc.edu/publichealth
Search By:
Jul 2024 – Research Associate Michelle Nieman (Lorenz lab) was elected to the University's Staff Senate, which advises the University's leadership.
Jul 2024 – Jean-Pierre Amoakon (Naren lab) has reviewed Pulmonary vascular dysfunctions in cystic fibrosis.
Jul 2024 – Dr. Schultz (left), who directs our PhD programs, welcomed Olesia Benedict, Ozgu Biler, Jenna Dunham, Jaedyn Haverstock, Claire Lopez, Carlin Moore, Taylor Peach, Valerie Plesha, and Madi Ringer.
Jul 2024 – The group reports that Inhibition of prefrontal cortex parvalbumin interneurons mitigates behavioral and physiological sequelae of chronic stress in male mice.
Jul 18, 2024 – Jean-Pierre Amoakon (Naren lab) received his Doctorate of Philosophy in Systems Biology and Physiology for his work "Mechanism of loss of small pulmonary blood vessels in cystic fibrosis".
Jul 25, 2024 – Kyle Harbour (Baccei lab) successfully defended his doctoral dissertation "Effects of stress on developing nociceptive circuits”.
Jul 2024 – The group has provided a review of Transforming obesity: The advancement of multi-receptor drugs.
Jul 2024 – She was the first and corresponding author on a collaborative study of Glucagon receptor antagonist for heart failure with preserved ejection fraction.
Jul 2024 – Dr. Schultz is leading the 2024 ASPET-SURF program to expose undergraduate students to research in Pharmacology.
Jul 2024 – She was the first author on a study reporting A new linc(-RNA) between NFAT/MEF2 and cardiac hypertrophy.
Department of Pharmacology, Physiology, & Neurobiology College of Medicine231 Albert Sabin WayCincinnati, OH 45267-0575